CHEM 30 B
Dr. R. Rinehart
Chapter
20 ENZYMES
ENZYMES are biological catalysts; without them, life would be impossible, since the thousands of reactions required to keep even a single cell alive would occur far too slowly to support life. With only a handful of exceptions, enzymes are proteins.
| PowerPoint-type presentations on enzymes and
vitamins by Warren Gallagher at the University of Wisconsin, Eau Claire http://www.chem.uwec.edu/Chem150_S06/Pages/Lecture-slides/C150_lect07_slides.html |
http://tutor.lscf.ucsb.edu/instdev/sears/biochemistry/tw-enz/tabs-enzymes-frames.htm or http://tutor.lscf.ucsb.edu/instdev/sears/biochemistry/ and select the enzyme tab near the top -- and as usual, the Netscape 4.7x version of Chime works better here. |
|
Enzyme
kinetics by Clarke Earley at Kent State University Stark Campus, OH |
| Reactions
and Enzymes by M. J. Farabee at
Estrella Mountain CC, Maricopa Cty, AZ Not too long, nice pictures, clear and concise; part of an online biology textbook http://gened.emc.maricopa.edu/bio/bio181/BIOBK/BioBookEnzym.html |
Enzymes
from Kimball’s Biology Pages by John Kimball
|
Enzyme
Biochemistry from MIT Biology Hypertextbook |
I. Enzyme characteristics
A. Globular proteins
(soluble enzymes; membrane-bound enzymes have extra hydrophobic segment)
B.
Catalytic efficiency:
accelerate reaction rate by 102 to 1020 times at
ordinary temperatures
C. Specificity for both
substrate and reaction catalyzed
1. absolute: works on only one substrate;
may be stereospecific, group-specific, linkage-specific
2. relative: works on several structurally-related substrates
3. reaction specificity minimizes byproduct formation and substrate waste
D. Catalytic activity can be regulated [see IV. E,F,G below]
II. Nomenclature and classification
A. Archaic: e.g.,
trypsin, chymotrypsin, pepsin, steapsin, amylopsin
B. Common: add -ase to name of substrate or to
combination of substrate name
and reaction catalyzed e.g., amylase, lipase, urease, lactate dehydrogenase
C. E.C. (from the international Enzyme Commission):
Six major classes based on type of reaction catalyzed [1st
#];
subclasses based on type of bond involved [2nd #], cofactors
required [3rd #],
and specific substrate
attacked [4th #]; name also ends in -ase
Each enzyme has a unique EC catalog number
1. Oxidoreductases: e.g., alcohol dehydrogenase,
EC 1.1.1.1
catalyze oxidation/reduction (electron transfer) reactions
2. Transferases e.g.,
hexokinase, EC 2.7.1.1
catalyze group transfer reactions
3. Hydrolases: e.g., chymotrypsin, EC 3.4.21.1
includes all digestive enzymes and many others
catalyze hydrolysis of esters, amides, thioesters, phosphate esters,
sulfate esters,
4. Lyases e.g., fumarase or fumarate
hydratase, EC 4.2.1.2
addition of H2O, NH3, etc. to double bonds or the
reverse reactions
5. Isomerases e.g., phosphohexose isomerase, EC
5.3.1.9
move a group from one position to another within a molecule or change DßàL
6. Ligases e.g. tyrosine -- tRNA ligase, EC
6.1.1.1
attach two smaller molecules together using energy from ATP or similar
source
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
| © Ronald W. Rinehart, 2002 Pictures made with MDL IsisDraw® |
III. Cofactors ( “activators”, coenzymes and
prosthetic groups):
nonprotein components required for catalytic activity
A. Inorganic: Ca+2, Mg+2, Zn+2,
Fe+2, Cl-, etc.; often called “activators”
B. Organic: “coenzymes”; usually derived from
vitamins
the term "prosthetic group" is used to describe coenzymes which
are "permanently" bound to their
enzyme [e.g., the heme group in cytochromes or FAD in succinate
dehydrogenase], while other
coenzymes such as NAD+ are "soluble" and exist in a pool
which can be utilized by many
different enzyme molecules.
IV. Enzyme activity
A. Mechanism [a mechanism is a detailed molecular picture of
exactly how a reaction happens]
1. Takes place at “active site”
2. Enzyme’s 3o structure is specifically designed to recognize
and bind substrate through
a combination of forces: electrostatic/ionic, dipolar, H-bonding,
dispersion/hydrophobic.
3. Active complex formation:
E + S ßà ES ßà ES* ßà EP ßà E + P
enzyme substrate(s) complex transition state complex enzyme product(s)
4. Mechanism of catalysis usually involves the side chains of from 2 to 5
amino acids
acting as precisely-positioned weak acids and bases with the
participation of any
cofactors required when the side chains alone can't do the job
| See an illustrated
discussion of an enzyme mechanism by Mark Bishop of MPC http://www.mpcfaculty.net/mark_bishop/chymotrypsin.htm |
| After reading
that, you will better appreciate the animated serine protease mechanism
from Gordon Rule's course at Carnegie Mellon University http://www.bio.cmu.edu/courses/03231/Protease/SerPro.htm we'll look at all this in greater depth on Wednesday |
B. Activity
1. Turnover number
2. Rate of substrate consumption (International
units) or product formation
C. Factors affecting rate
1. Enzyme concentration
2. Substrate concentration
3. Temperature
4. pH
![]() |
![]() |
![]() |
![]() |
D. Inhibition of enzymes
1. Irreversible; e.g.
heavy metal or cyanide poisoning
2. Reversible
a. Competitive: overcome by
increasing [S]; Ic ~ S in structure
b. Noncompetitive: not overcome by increasing [S]; In
must be removed
useful
in feedback inhibition of metabolic pathways
E. Regulation of enzymes
1. Activation of zymogens/proenzymes
2. Allosteric modulation: can increase or decrease
activity; noncompetitive
can coordinate several pathways via feedback inhibition
3. Covalent modification:
phosphorylation/dephosphorylation,
acetylation/deacetylation,
methylation/demethylation, etc.
4. Genetic control: induction and repression; alter amount of
enzyme itself
5. Proteolysis will eventually inactivate all enzymes; for some,
this may be programmed.
6. Hormones can affect both quantity and specific activity of
enzymes via one
or more of the mechanisms listed above.
V. Medical applications of enzymes
A. Inborn errors of metabolism
B. Serum enzyme analysis
C. Isoenzymes
D. Therapeutic use of enzymes: e.g.,
streptokinase for dissolving clots
|
See how an understanding of enzyme structure and mechanisms led to the development of an inhibitor of the HIV protease at http://stingray.bio.cmu.edu/~web/bc/Lec/Lec18/lec18.html |
©
Ronald W. Rinehart, 2002, 2004, 2006